Llwytho...
Cell therapy for peripheral artery disease
Patients with severe peripheral artery disease (PAD) who are not candidates for revascularization have poor prognosis. Cell therapy using peripheral blood- or bone marrow-derived mononuclear cells, mesenchymal stem cells, or marker-specific subsets of bone marrow cells with angiogenic properties may...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Opin Pharmacol |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019642/ https://ncbi.nlm.nih.gov/pubmed/29452987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.01.005 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|